Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosisFrédéric Hilezian, Adil Maarouf, Clemence Boutiere, et al.Neurology and Therapy|February 10, 2023
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French CohortJuliette Pelle, Anais R Briant, Pierre Branger, et al.Multiple Sclerosis and Related Disorders|July 15, 2023
The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchersGuillaume Brocard, Romain Casey, Nathalie Dufay, et al.European Journal of Neurology|February 2, 2021
The long-term outcome of MOGAD: An observational national cohort study of 61 patientsRomain Deschamps, Julie Pique, Xavier Ayrignac, et al.Annals of Clinical and Translational Neurology|September 10, 2021
A meta-analysis comparing first-line immunosuppressants in neuromyelitis opticaJonathan Giovannelli, Jonathan Ciron, Mikael Cohen, et al.Journal of Neuroinflammation|April 25, 2020
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodiesElisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, et al.Journal of Neurology|February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.Neurology|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024Thomas Roux, François-Xavier Lejeune, Romain Casey, et al.Journal of Neurology|January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.Journal of Neuroinflammation|July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated diseaseAlvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.Pageof 10